166 related articles for article (PubMed ID: 10225552)
21. Cellular kinetics in rectal cancer.
Terry NH; Meistrich ML; Roubein LD; Lynch PM; Dubrow RA; Rich TA
Br J Cancer; 1995 Aug; 72(2):435-41. PubMed ID: 7640229
[TBL] [Abstract][Full Text] [Related]
22. Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy.
Gasińska A; Urbański K; Jakubowicz J; Klimek M; Biesaga B; Wilson GD
Radiother Oncol; 1999 Jan; 50(1):77-84. PubMed ID: 10225560
[TBL] [Abstract][Full Text] [Related]
23. Chemoradiotherapy as an alternative to radiotherapy alone in fast proliferating head and neck squamous cell carcinomas.
Corvó R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Orecchia R; Benasso M; Numico GM; Merlano M; Margarino G; Vitale V
Clin Cancer Res; 1997 Nov; 3(11):1993-7. PubMed ID: 9815589
[TBL] [Abstract][Full Text] [Related]
24. Proliferative characteristics of head and neck tumors. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry.
Benazzo M; Mevio E; Occhini A; Franchini G; Danova M
ORL J Otorhinolaryngol Relat Spec; 1995; 57(1):39-43. PubMed ID: 7700609
[TBL] [Abstract][Full Text] [Related]
25. Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables.
Tsang RW; Fyles AW; Li Y; Rajaraman MM; Chapman W; Pintilie M; Wong CS
Radiother Oncol; 1999 Jan; 50(1):85-92. PubMed ID: 10225561
[TBL] [Abstract][Full Text] [Related]
26. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.
Begg AC; Moonen L; Hofland I; Dessing M; Bartelink H
Radiother Oncol; 1988 Apr; 11(4):337-47. PubMed ID: 3375460
[TBL] [Abstract][Full Text] [Related]
27. [In vivo evaluation of potential doubling time (Tpot) of tumors by flow cytometry: practical difficulties and possible solutions].
Gorisse MC; Desoize B; Carpentier Y; Nguyen TD
Bull Cancer; 1996 Oct; 83(10):825-34. PubMed ID: 8952632
[TBL] [Abstract][Full Text] [Related]
28. Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome.
Tsang RW; Wong CS; Fyles AW; Levin W; Manchul LA; Milosevic M; Chapman W; Li YQ; Pintilie M
Radiother Oncol; 1999 Jan; 50(1):93-101. PubMed ID: 10225562
[TBL] [Abstract][Full Text] [Related]
29. Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.
Forster G; Cooke TG; Cooke LD; Stanton PD; Bowie G; Stell PM
Br J Cancer; 1992 May; 65(5):698-702. PubMed ID: 1586597
[TBL] [Abstract][Full Text] [Related]
30. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.
Wilson GD; McNally NJ; Dische S; Saunders MI; Des Rochers C; Lewis AA; Bennett MH
Br J Cancer; 1988 Oct; 58(4):423-31. PubMed ID: 3207597
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
Edström S; Cvetkovska E; Westin T; Young C
Laryngoscope; 2001 Jan; 111(1):124-30. PubMed ID: 11192880
[TBL] [Abstract][Full Text] [Related]
32. Cell kinetics and tumor regression during radiotherapy in head and neck squamous-cell carcinomas.
Corvò R; Giaretti W; Geido E; Sanguineti G; Orecchia R; Scala M; Garaventa G; Mora E; Vitale V
Int J Cancer; 1996 Oct; 68(2):151-5. PubMed ID: 8900419
[TBL] [Abstract][Full Text] [Related]
33. Repopulation kinetics during fractionated irradiation and the relationship to the potential doubling time, Tpot.
Speke AK; Hill RP
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):847-56. PubMed ID: 7860398
[TBL] [Abstract][Full Text] [Related]
34. Age and bromodeoxyuridine labelling index as prognostic factors in high-grade gliomas treated with surgery and radiotherapy.
Gasinska A; Skolyszewski J; Glinski B; Niemiec J; Adamczyk A; Krzyszkowski T; Zabek M
Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):459-65. PubMed ID: 16909969
[TBL] [Abstract][Full Text] [Related]
35. Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine.
Erba E; Giordano M; Danova M; Mazzini G; Ubezio P; Torri V; Mangioni C; Landoni F; Bolis P; Tenti P
Ann Oncol; 1994 Sep; 5(7):627-34. PubMed ID: 7993839
[TBL] [Abstract][Full Text] [Related]
36. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy.
Geara FB; Peters LJ; Ang KK; Garden AS; Tucker SL; Levy LB; Brown BW
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):455-62. PubMed ID: 8655367
[TBL] [Abstract][Full Text] [Related]
37. [The in vivo use of bromodeoxyuridine for the study of cell kinetics in squamous tumors of the neck and head. Implications for the radiotherapist].
Corvò R; Giaretti W; Margarino G; Danova M; Vitale V
Radiol Med; 1991; 82(1-2):147-52. PubMed ID: 1896568
[TBL] [Abstract][Full Text] [Related]
38. In vivo cell kinetics in elderly patients affected by squamous cell carcinoma of the head and neck.
Corvò R; Sanguineti G; Vitale V; Bacigalupo A; Margarino G; Benasso M; Numico GM; Giaretti W
Rays; 1997; 22(1 Suppl):69-72. PubMed ID: 9250019
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
[TBL] [Abstract][Full Text] [Related]
40. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine.
Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE
Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
